Showing results (471-480 of 597) with videos related to

Sort By:
Pageof 60
JACC. Cardiovascular Imaging|December 10, 2021
First-Phase Ejection Fraction Predicts Response to Cardiac Resynchronization Therapy and Adverse OutcomesHaotian Gu, Baldeep S Sidhu, Lingyun Fang, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 25, 2010
Cardiac MRI to investigate myocardial scar and coronary venous anatomy using a slow infusion of dimeglumine gadobenate in patients undergoing assessment for cardiac resynchronization therapySimon G Duckett, Amedeo Chiribiri, Matthew R Ginks, et al.
Plos One|May 5, 2023
Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesotheliomaM Lizeth Orozco Morales, Catherine A Rinaldi, Emma de Jong, et al.
Physiological Research|July 28, 2022
Antisenescence effect of REAC biomodulation to counteract the evolution of myelodysplastic syndromeM Maioli, S Rinaldi, S Cruciani, et al.
Heart Rhythm|July 29, 2023
Left bundle branch area pacing reduces epicardial dispersion of repolarization compared with biventricular cardiac resynchronization therapyMark K Elliott, Marina Strocchi, Benjamin J Sieniewicz, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|November 16, 2016
Healthcare Associated Infections: educational intervention by "Adult Learning" in an Italian teaching hospitalA Rinaldi, A Marani, M Montesano, et al.
Heart Rhythm O2|September 12, 2024
Optimizing electrical efficacy of leadless cardiac resynchronization therapy and leadless left ventricular septal pacing: Insights on left and right ventricular activation from electrocardiographic imagingNadeev Wijesuriya, Marina Strocchi, Mark Elliott, et al.
Pacing and Clinical Electrophysiology : PACE|March 23, 2016
Improvement of Right Ventricular Hemodynamics with Left Ventricular Endocardial Pacing during Cardiac Resynchronization TherapyEoin R Hyde, Jonathan M Behar, Andrew Crozier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
Frontiers in Physiology|June 15, 2017
Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential DurationBradley Porter, Martin J Bishop, Simon Claridge, et al.
Pageof 60